Top Markets
Coin of the day
Oxford Cannabinoid Technologies Holdings Plc Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies Holdings Plc

OCTP
Rank in Stocks #41534
Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical... Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical company, focused on the research, development, and commercialization of cannabinoid-derived prescription medications. Their principal drug candidate, OCT461201, is a selective CB2 receptor agonist in an oral solid dosage format, currently undergoing pre-clinical assessment. It is being developed to target visceral pain associated with Irritable Bowel Syndrome (IBS), as well as a range of neuropathic pain conditions, notably post-herpetic neuralgia. The company is also progressing with OCT130401, another compound in pre-clinical development, intended for the treatment of trigeminal neuralgia. Incorporated in 2017, Oxford Cannabinoid Technologies Holdings Plc is based in London, United Kingdom.
Share Price
$0.00156481
Last synced: 2024-06-05
Market Cap
$17.03K
Change (1 day)
2.11%
Change (1 year)
0.00%
Country
GB
Trade Oxford Cannabinoid Technologies Holdings Plc (OCTP)

Category

Number of shares outstanding for Oxford Cannabinoid Technologies Holdings Plc (OCTP)
Number of shares outstanding as of August 2026: 0
According to Oxford Cannabinoid Technologies Holdings Plc latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Oxford Cannabinoid Technologies Holdings Plc (OCTP) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE